Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 5 | BMC Cancer

Figure 5

From: Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker

Figure 5

Serum TK1 activity, STK1 protein levels and STK1 specific activities in different groups. (A) STK1 activities in sera from blood donors (•), MDS (■), breast (▲) and prostate cancer patients (). (B) STK1 protein levels in sera from blood donors (•), MDS (■), breast (▲) and prostate cancer patients (). (C) Specific activities of TK1 in sera from blood donors (•), MDS (■), breast (▲) and prostate cancer patients ().

Back to article page